Form D/A - Notice of Exempt Offering of Securities: [Amend]
SEC Accession No. 0000897069-24-001528
Filing Date
2024-07-19
Accepted
2024-07-19 17:17:42
Documents
1
Effectiveness Date
2024-07-19
Items
Item 06b:
Item 3C: Investment Company Act Section 3(c)
Item 3C.7: Section 3(c)(7)

Document Format Files

Seq Description Document Type Size
1 primary_doc.html D/A  
1 primary_doc.xml D/A 7298
  Complete submission text file 0000897069-24-001528.txt   8536
Mailing Address 1001 PAGE MILL ROAD BUILDING 4, SUITE B PALO ALTO CA 94304
Business Address 1001 PAGE MILL ROAD BUILDING 4, SUITE B PALO ALTO CA 94304 (650) 325-5156
Frazier Life Sciences Public Overage Fund, L.P. (Filer) CIK: 0001913804 (see all company filings)

EIN.: 880646551 | State of Incorp.: DE | Fiscal Year End: 1231
Type: D/A | Act: 33 | File No.: 021-517439 | Film No.: 241128522